Meilleure Health Delays Dispatch of Circular on Equity Interest Transfer

Meilleure Health International Industry Group Limited ( (HK:2327) ) has issued an announcement.

Meilleure Health International Industry Group Limited has announced a further delay in sending a shareholder circular related to a disclosable and connected transaction involving an equity interest transfer agreement. The circular, which will include transaction details, independent board and adviser recommendations, a valuation report and notice of a special general meeting, is now expected to be dispatched on or before 10 April 2026, potentially extending the timeline for shareholder review and approval.

The postponement reflects the company’s need for additional time to prepare and finalise certain information required in the circular. While procedural in nature, the delay may briefly defer decision-making on the equity interest transfer, leaving shareholders and other stakeholders waiting longer for clarity on the transaction’s terms and its implications for the group’s future structure and strategy.

The most recent analyst rating on (HK:2327) stock is a Hold with a HK$0.25 price target. To see the full list of analyst forecasts on Meilleure Health International Industry Group Limited stock, see the HK:2327 Stock Forecast page.

More about Meilleure Health International Industry Group Limited

Meilleure Health International Industry Group Limited is a Bermuda-incorporated company listed on the Hong Kong Stock Exchange under stock code 2327. The group operates within the broader health-related industry and is overseen by a board comprising executive, non-executive and independent non-executive directors, reflecting a typical Hong Kong-listed corporate governance structure.

Average Trading Volume: 1,703,084

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$974.3M

Find detailed analytics on 2327 stock on TipRanks’ Stock Analysis page.